Adagio Medical Holdings ADGM
NASDAQ ADGM
$0.66 +0.03 (+3.98%)
As of: Aug 21, 2026 · 1:07 PM EDT

Adagio Medical Holdings (ADGM) Gross Margin (2023 - 2024)

Adagio Medical Holdings (ADGM) posted Gross Margin of 213.64% for Q3 2024, down 26.78% sequentially from 168.5% in Q2 2024, and up 30344.0% YoY from N/an in Q4 2023.

Adagio Medical Holdings (ADGM) Gross Margin (2023 - 2024) Analysis & Trends

Adagio Medical Holdings has reported Gross Margin for 2 years, with the latest figure at 213.64% in Q3 2024.

  • Quarterly Gross Margin rose 30344.0% year-over-year to 213.64% in Q3 2024, while the trailing twelve-month figure through Dec 2025 was 472.73% (changed N/A YoY) and the FY2024 annual result came in at 620.07%, down 28474.0% from the prior year.
  • Gross Margin declined to 213.64% in Q3 2024 per ADGM's latest filing, from 168.5% in the prior quarter.
  • Over five years, Gross Margin peaked at 168.5% in Q2 2024 and troughed at 1984.62% in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Abbott Laboratories 202.23 Bn 196.63 Bn 7.27 Bn 57.71%
2 Stryker 127.28 Bn 123.80 Bn 4.50 Bn 68.27%
3 Medtronic 119.00 Bn 109.78 Bn 6.41 Bn 65.35%
4 Boston Scientific 74.41 Bn 73.88 Bn 3.85 Bn 70.71%
5 Edwards Lifesciences 51.77 Bn 47.52 Bn 1.35 Bn 77.46%
6 Dexcom 35.03 Bn 33.09 Bn 830.00 Mn 63.44%
7 GE HealthCare Technologies 33.80 Bn 31.69 Bn 2.18 Bn 41.17%
8 Koninklijke Philips 26.24 Bn 22.92 Bn 4.55 Bn 47.38%
9 Steris 23.20 Bn 22.71 Bn 684.20 Mn 45.84%
10 Adagio Medical Holdings 14.55 Mn 14.55 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 -213.64%
Jun 30, 2024 -168.50%
Mar 31, 2024 -1,984.62%
Dec 31, 2023 -328.21%
Sep 30, 2023 -517.07%